Droplette Device
Transdermal drug delivery platform
Pre-clinical/DevelopmentActive
Key Facts
Indication
Transdermal drug delivery platform
Phase
Pre-clinical/Development
Status
Active
Company
About Novopyxis
Novopyxis is a private, preclinical-stage biotech firm pioneering a physics- and mathematics-driven platform for drug discovery and delivery. Its core technology applies knot theory and fluid dynamics to design peptide drugs for uncrystallized protein targets and to engineer a painless, needle-free transdermal delivery system. The company's lead therapeutic candidate, NP-6A, is an AT2R agonist for cardiomyopathy, while its Droplette device aims to deliver large-molecule drugs into the skin. With backing from prestigious academic and government partners, Novopyxis is positioning itself at the intersection of computational biology and advanced medical device engineering.
View full company profile